| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9886b25e35640a93615e91960610cb5b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-916 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate |
2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_565e3de5c5be17ce0afa47aa19f01674
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c37d1648f0653e849c42a3d1e6a4bac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c6a3b240d09f46dacd9d8436b0aa9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_260e7c3418ec58bd510371738ef5f2fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_856a2970fded71af71c6a7e7bbd12747 |
| publicationDate |
2021-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113667713-A |
| titleOfInvention |
A method and application for reducing the risk of renal damage |
| abstract |
The present invention provides a method for testing whether an individual receives the combined treatment of antihypertensive drugs and folic acid to reduce the risk of renal damage and its application; the invention also relates to a kit for testing whether the individual receives the above-mentioned combined treatment. The present invention determines a better medication plan for hypertensive patients through specific laboratory testing items, that is, individualized medication is implemented, so as to achieve the purpose of improving clinical curative effect. |
| priorityDate |
2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |